These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6302341)

  • 21. Ceftriaxone: increasing the half-life and activity of third generation cephalosporins.
    Steele RW
    Pediatr Infect Dis; 1985; 4(2):188-91. PubMed ID: 3885182
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical evaluation of ceftizoxime in the pediatric infections (author's transl)].
    Mashiko J; Meguro H; Ozawa S; Togo T; Nonaka C; Hiraiwa M; Fujii R
    Jpn J Antibiot; 1982 Jan; 35(1):1-8. PubMed ID: 6279902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical experience with ceftizoxime in the pediatric field (author's transl)].
    Hosoda T; Tomimatsu H; Ohara K; Okamoto T
    Jpn J Antibiot; 1982 Jan; 35(1):81-90. PubMed ID: 6279915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefmenoxime versus cefoxitin in the treatment of serious bacterial infections.
    Tan JS; File TM
    Am J Med; 1984 Dec; 77(6A):51-2. PubMed ID: 6097125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fundamental and clinical studies on ceftizoxime (author's transl)].
    Okada T; Hirao F; Furukawa S
    Jpn J Antibiot; 1982 Jan; 35(1):91-104. PubMed ID: 6279917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic use of cefotiam in bacterial infections in pediatrics].
    Cerutti F; Gusmano R; Pedrinazzi RC; Ramenghi U; Spada A; Vassena E
    Minerva Pediatr; 1983 Nov; 35(21):1073-8. PubMed ID: 6323941
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on a new cephalosporin, cefotiam, in the pediatric field (author's transl)].
    Nakazawa S; Sato H; Niino K; Nakazawa S; Suzuki H; Iwasaki A; Hirama Y; Narita A; Chikaoka H; Oka S
    Jpn J Antibiot; 1981 May; 34(5):670-7. PubMed ID: 6270407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Basic and clinical studies on cefmenoxime in pediatric field].
    Iwai N; Taneda Y; Sasaki A; Inokuma K; Mizoguchi F; Nakamura H
    Jpn J Antibiot; 1982 Oct; 35(10):2468-90. PubMed ID: 6306298
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical experience with cefodizime on pediatric infections].
    Haruta T; Okura K; Kuroki S; Matsuda T; Kobayashi Y
    Jpn J Antibiot; 1989 Jun; 42(6):1381-4. PubMed ID: 2795861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Review [new antibiotics series II]: cefotaxime (author's transl)].
    Fujii R
    Jpn J Antibiot; 1982 Feb; 35(2):296-317. PubMed ID: 6283193
    [No Abstract]   [Full Text] [Related]  

  • 31. Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies.
    LeFrock JL; Molavi A; McCloskey RV; Rolston K; Chandrasekar P; Henao L; Smith BR; Kannangara W; Schell RF; Carr BB
    Am J Med; 1984 Jul; 77(1):72-8. PubMed ID: 6331163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Bryskier A; Humbert G; Borsa F; Bertrand A; Janbon F; Lafaix C; Beucler A; Veyssier P; Dusehu E; Modai J
    Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetic, bacteriological and clinical studies of cefotaxime in newborn and immature infants].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F; Takajo N; Araki H; Imai S; Yuasa T; Tanaka Y; Tsugawa S; Nagayama K; Hashimoto T; Nakajima H; Matsuo H; Imuta F
    Jpn J Antibiot; 1982 Jul; 35(7):1819-45. PubMed ID: 6294363
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical evaluation of ceftriaxone in the pediatric field].
    Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
    Jpn J Antibiot; 1984 Nov; 37(11):2027-33. PubMed ID: 6098699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of cefmenoxime in internal medicine, with special reference to infections associated with hematological disorders].
    Uchida T; Matsuda S; Kimura H; Satoh T; Ishibashi T; Kokubun K; Umezu H; Horikawa A; Saitoh T; Sakauchi Y
    Jpn J Antibiot; 1984 Dec; 37(12):2506-18. PubMed ID: 6098743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical results and concentrations of cefmenoxime in serum, amniotic fluid, mother's milk, and umbilical cord.
    Weissenbacher ER; Adams D; Gutschow K; Peters-Welte C; Luehr HG
    Am J Med; 1984 Dec; 77(6A):11-2. PubMed ID: 6097116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A clinical study of cefotiam in pediatric field (author's transl)].
    Aoyama R; Nagata K; Izumi Y; Kuronuma T; Asuka N
    Jpn J Antibiot; 1981 May; 34(5):678-81. PubMed ID: 6270408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the intravenous administration of cefmenoxime in pediatric field].
    Nakazawa S; Sato H; Niino K; Hirama Y; Narita A; Nakazawa S; Chikaoka H; Oka S
    Jpn J Antibiot; 1982 Oct; 35(10):2393-404. PubMed ID: 6306291
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fundamental and clinical studies on cefmenoxime in the field of pediatrics].
    Toyonaga Y; Sugita M; Kawamura G; Kurosu Y; Horiuchi K; Hori M; Kohno S; Tatsusawa O; Takahashi T
    Jpn J Antibiot; 1982 Oct; 35(10):2423-39. PubMed ID: 6306294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.